Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis

Scandinavian Journal of Rheumatology
P A KlimiukJ Chwiecko

Abstract

Endothelium and adhesion molecules are engaged in the pathogenesis of rheumatoid arthritis (RA). This study was undertaken to analyse the effect of etanercept on the levels of soluble cell adhesion molecules (sCAMs) and vascular endothelial growth factor (VEGF) in patients with active RA. Patients were receiving 50 mg/week of subcutaneous etanercept and 10-25 mg/week of methotrexate (MTX). Serum levels of soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-selectin), and VEGF were measured by enzyme-linked immunosorbent assay (ELISA) in 18 RA patients (prior to injection) at 0, 3, 6, 9, and 12 months. A decrease in serum levels of sICAM-1 (p<0.001), sVCAM-1 (p<0.01), sE-selectin (p<0.01), and VEGF (p<0.001) was observed in RA patients after 3 months of treatment with etanercept. Six months of therapy with etanercept prolonged the suppression of serum sICAM-1 (p<0.01) and even more remarkably diminished sVCAM-1, sE-selectin, and VEGF (in all cases p<0.001) concentrations as compared to baseline (month 0). Treatment also effectively diminished sICAM-1, sVCAM-1, and VEGF levels at months 9 and 12 (in all cases p<0.001), and less significantly sE-selectin (p<0.05 at month...Continue Reading

References

Dec 1, 1995·Clinical Immunology and Immunopathology·P P TakF C Breedveld
Feb 1, 1996·Seminars in Arthritis and Rheumatism·R W McMurray
Oct 1, 1996·British Journal of Rheumatology·E M Paleolog
Jun 1, 1997·Arthritis and Rheumatism·C F Mojcik, E M Shevach
Nov 10, 1998·Scandinavian Journal of Rheumatology·M HaradaK Tanikawa
Mar 13, 1999·Annals of Internal Medicine·L W MorelandM E Weinblatt
Jul 26, 2000·Rheumatology·E L NassonovD Fuchs
May 16, 2001·Arthritis and Rheumatism·R A Carter, I P Wicks
Feb 9, 2006·Annals of the Rheumatic Diseases·P L C M van RielUNKNOWN Add Enbrel or Replace Methotrexate Study Investigators
Jun 25, 1949·Journal of the American Medical Association·O STEINBROCKERR C BATTERMAN

❮ Previous
Next ❯

Citations

Feb 19, 2013·Immunotherapy·Giuseppe MurdacaFrancesco Puppo
Dec 19, 2013·Genetics Research International·Do Young KimDongsik Bang
Jun 27, 2014·International Journal of Molecular Sciences·Curtis M Steyers, Francis J Miller
Jan 29, 2014·International Journal of Rheumatic Diseases·Gholamreza AziziAbbas Mirshafiey
Dec 8, 2004·The American Journal of Pathology·Yong Wook ParkCornelia M Weyand
Nov 16, 2011·Nature Reviews. Rheumatology·Jeffrey D GreenbergMichael E Farkouh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Related Papers

Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
Toshikatsu KaburakiKouji Matsushima
Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]
A GuglielmottiM Pinza
© 2022 Meta ULC. All rights reserved